United Therapeutics Corp. (UTHR)
546.14
-3.73
(-0.68%)
USD |
NASDAQ |
Jun 08, 13:34
United Therapeutics Market Cap : 23.02B for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| MannKind Corp. | 1.058B |
| Catalyst Pharmaceuticals, Inc. | 3.822B |
| Insmed, Inc. | 20.54B |
| Alnylam Pharmaceuticals, Inc. | 38.55B |
| BioMarin Pharmaceutical, Inc. | 10.87B |
Market Cap Related Metrics
| PE Ratio | 20.16 |
| PS Ratio | 8.188 |
| PEG Ratio | 2.479 |
| Price to Book Value | 3.902 |
| Price to Free Cash Flow | 25.66 |
| Price | 546.14 |
| Earnings Yield | 4.96% |
| PEGY Ratio | 2.479 |
| Operating PE Ratio | 17.79 |
| Normalized PE Ratio | 21.17 |